From: Mail Delivery System <Mailer-Daemon@lists.sourceforge.net>
To: alsa-devel@lists.sourceforge.net
Subject: Mail delivery failed: returning message to sender
Date: Thu, 05 Oct 2006 09:58:04 -0700 [thread overview]
Message-ID: <E1GVWXs-0000Hu-7A@externalmx-1.sourceforge.net> (raw)
This message was created automatically by mail delivery software.
A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:
alsa-devel@lists.sourceforge.net
SMTP error from remote mailer after RCPT TO:<alsa-devel@lists.sourceforge.net>:
host mail.sourceforge.net [66.35.250.206]: 451-Could not complete sender verify callout
451-Could not complete sender verify callout for
451-<alsa-devel@lists.sourceforge.net>.
451-The mail server(s) for the domain may be temporarily unreachable, or
451-they may be permanently unreachable from this server. In the latter case,
451-you need to change the address or create an MX record for its domain
451-if it is supposed to : retry timeout exceeded
------ This is a copy of the message, including all the headers. ------
Return-path: <alsa-devel@lists.sourceforge.net>
Received: from [219.128.237.98] (helo=219.128.237.98)
by externalmx-1.sourceforge.net with esmtp (Exim 4.41)
id 1GU2D2-0001l5-97
for alsa-devel@lists.sourceforge.net; Sun, 01 Oct 2006 07:22:25 -0700
Received: from [171.171.210.211] (helo=[6644245465])
by 219.128.237.98 with smtp (Exim 4.60 (FreeBSD))
(envelope-from <jpgoguvmwo@diamondsystems.com>)
id rKO-BPUq6M-dh
for alsa-devel@lists.sourceforge.net; Sun, 01 Oct 2006 22:22:08 +0800
Received: from diamondsystems.com (8178470400 [258737474])
by DIAMOND1.INETU.NET (Qmailv1) with ESMTP id YEX7054AI6K
for <alsa-devel@lists.sourceforge.net>; Sun, 01 Oct 2006 15:30:26 +0200
Date: Sun, 01 Oct 2006 15:30:26 +0200
From: " Mcdonald" <jpgoguvmwo@diamondsystems.com>
X-Mailer: Pegasus Mail for Win32 (v2.53/R1)
X-Priority: 3
Message-ID: <5763726108124.2006100115302641251631@diamondsystems.com>
To: alsa-devel@lists.sourceforge.net
Subject: sir, said, confusedly, I guess not a colony, the
MIME-Version: 1.0
Content-Type: text/plain; charset=windows-1258
Content-Transfer-Encoding: 7bit
X-Spam-Score: 3.5 (+++)
X-Spam-Report: Spam Filtering performed by sourceforge.net.
See http://spamassassin.org/tag/ for more details.
Report problems to https://sf.net/tracker/?func=add&group_id=1&atid=200001
0.0 RCVD_BY_IP Received by mail server with no name
1.5 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO
0.0 SF_CHICKENPOX_PERIOD BODY: Text interparsed with .
0.0 SF_CHICKENPOX_MINUS BODY: Text interparsed with -
0.0 SF_CHICKENPOX_AMPERSAND BODY: Text interparsed with &
1.8 STOCK_ALERT BODY: Offers a alert about a stock
0.0 SF_CHICKENPOX_APOSTROPHE BODY: Text interparsed with '
0.1 RCVD_IN_SORBS_DUL RBL: SORBS: sent directly from dynamic IP address
[219.128.237.98 listed in dnsbl.sorbs.net]
HOT STOCK ALERT - THIS ONE IS STILL CLIMBING THE STOCK CHARTS ALERT --
BREAKING MARKET NEWS REPORT ---- PGCN.OB
Company: Pingchuan Pharmaceutical Inc.
Ticker: PGCN.OB
Current Price: $.26
5-Day Target: $1.5 - $2
Rating: 10(10)
Recommendation: S T R 0 N G - B U Y !!
This quick rising stock is a good long term winner. This stock is
going high due to superb business solutions and creative partnerships
in the business world.
Could this company be the next PFIZER??
Pingchaun Pharmaceuticals disributes its medications to over 50
percent of CHINA and has a tremendous presence via exports to U.S.A,
Russia, Japan and South-Eastern Asia. They have partnerships with the
biggest drugstores, equivalent in the US to SAV-ON, CVS, RITE-AID,
etc. With BIG NEWS anticipated this coming WEEK we strongly advise
you to get in EARLY and issue
a 10/10 Alert.
About Pingchuan Pharmaceutical Inc.
Pingchuan Pharmaceutical Inc. ("PINGCHUAN") is a modernized
pharmaceutical manufacturer with first-class medical R&D ability,
pioneered medicine products, and well-established marketing network.
Since its establishment, PINGCHUAN has focused its businesses on
diabetes medicine and its medical products. The products of PINGCHUAN
include health care products, varieties of medicine, as well as
medical apparatus. Kang Da Glycosuria Capsule is a successful product
of PINGCHUAN for treating diabetes, which was first developed in 1998
and introduced to the market in 2001. PINGCHUAN has well-established
marketing network and sale branches, which include about 180,000
retail pharmacies /drugstores across China, agency network in major
cities like Beijing, Shanghai, Guangzhou, and Xi'an, special counter
sale at drug chain stores in key regions, residence community clinic
sale and promotion, as well as internet marketing through the
company's website. The marketing network of PINGCHUAN covers more than
50 percent districts
of China and exports to US, Japan, Russia, and south-eastern Asia.
Dont miss the boat, this is a new issue, is thinly traded and could
move up quickly. We anticipate that shares of PGCN will be much
higher in the short-term. ACT NOW!
Remember the gains from our recent recommendations... Do not miss out,
Put PGCN.OB on your radar's now. Good luck and trade out at the top!!
-------------------------------------------------------------------------
Take Surveys. Earn Cash. Influence the Future of IT
Join SourceForge.net's Techsay panel and you'll get the chance to share your
opinions on IT & business topics through brief surveys -- and earn cash
http://www.techsay.com/default.php?page=join.php&p=sourceforge&CID=DEVDEV
next reply other threads:[~2006-10-05 16:58 UTC|newest]
Thread overview: 54+ messages / expand[flat|nested] mbox.gz Atom feed top
2006-10-05 16:58 Mail Delivery System [this message]
-- strict thread matches above, loose matches on Subject: below --
2007-03-19 15:18 Mail delivery failed: returning message to sender Mail Delivery System
2007-03-18 12:04 Mail Delivery System
2007-03-16 6:11 Mail Delivery System
2007-03-15 13:09 Mail Delivery System
2007-03-15 12:35 Mail Delivery System
2007-03-14 4:07 Mail Delivery System
2007-03-13 20:06 Mail Delivery System
2007-03-11 10:26 Mail Delivery System
2007-03-10 20:06 Mail Delivery System
2007-03-07 17:45 Mail Delivery System
2007-03-03 1:05 Mail Delivery System
2007-03-01 14:27 Mail Delivery System
2007-02-27 5:10 Mail Delivery System
2007-02-27 1:07 Mail Delivery System
2007-02-24 12:53 Mail Delivery System
2007-02-23 11:08 Mail Delivery System
2007-02-21 16:29 Mail Delivery System
2007-02-21 14:46 Mail Delivery System
2007-02-20 14:58 Mail Delivery System
2007-02-20 14:33 Mail Delivery System
2007-02-17 11:19 Mail Delivery System
2007-02-16 19:31 Mail Delivery System
2007-02-14 22:31 Mail Delivery System
2007-02-14 14:29 Mail Delivery System
2007-02-13 7:35 Mail Delivery System
2007-02-12 5:27 Mail Delivery System
2007-02-04 16:40 Mail Delivery System
2007-01-31 13:43 Mail Delivery System
2007-01-31 1:24 Mail Delivery System
2007-01-27 5:43 Mail Delivery System
2007-01-27 4:48 Mail Delivery System
2007-01-25 21:50 Mail Delivery System
2007-01-21 7:12 Mail Delivery System
2007-01-19 11:06 Mail Delivery System
2007-01-13 14:05 Mail Delivery System
2007-01-11 2:52 Mail Delivery System
2007-01-10 5:43 Mail Delivery System
2007-01-07 17:57 Mail Delivery System
2007-01-06 1:52 Mail Delivery System
2007-01-04 16:36 Mail Delivery System
2007-01-03 17:58 Mail Delivery System
2006-12-12 11:24 Mail Delivery System
2006-11-22 1:50 Mail Delivery System
2006-11-20 3:36 Mail Delivery System
2006-11-19 11:08 Mail Delivery System
2006-11-16 16:40 Mail Delivery System
2006-11-14 19:58 Mail Delivery System
2006-11-07 18:08 Mail Delivery System
2006-10-28 0:48 Mail Delivery System
2005-11-30 8:21 Mail Delivery System
2005-07-16 9:52 Mail Delivery System
2004-09-13 19:39 Mail Delivery System
2004-09-11 4:12 Mail Delivery System
Reply instructions:
You may reply publicly to this message via plain-text email
using any one of the following methods:
* Save the following mbox file, import it into your mail client,
and reply-to-all from there: mbox
Avoid top-posting and favor interleaved quoting:
https://en.wikipedia.org/wiki/Posting_style#Interleaved_style
* Reply using the --to, --cc, and --in-reply-to
switches of git-send-email(1):
git send-email \
--in-reply-to=E1GVWXs-0000Hu-7A@externalmx-1.sourceforge.net \
--to=mailer-daemon@lists.sourceforge.net \
--cc=alsa-devel@lists.sourceforge.net \
/path/to/YOUR_REPLY
https://kernel.org/pub/software/scm/git/docs/git-send-email.html
* If your mail client supports setting the In-Reply-To header
via mailto: links, try the mailto: link
Be sure your reply has a Subject: header at the top and a blank line
before the message body.
This is a public inbox, see mirroring instructions
for how to clone and mirror all data and code used for this inbox;
as well as URLs for NNTP newsgroup(s).